1.- Fuster V,
Rydén LE,
Cannom DS,
Crijns HJ,
Curtis AB,
et al.
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
J Am Coll Cardiol.
2011 15;57:101-98.
2.- Go AS,
Hylek EM,
Phillips KA,
Chang Y,
Henault LE,
et al Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
JAMA.
2001 9;285:2370-5.
3.- Shroff GS,
Guirguis MS,
Ferguson EC,
Oldham SA,
Kantharia BK.
CT imaging of complications of catheter ablation for atrial fibrillation.
Clin Radiol.
2014;69:96-102
4.- Calkins H,
Kuck KH,
Cappato R,
Brugada J,
Camm AJ,
et al.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection,
procedural techniques,
patient management and follow-up,
definitions,
endpoints,
andresearch trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation.
Developed in partnership with the European Heart Rhythm Association (EHRA),
a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC),
American Heart Association (AHA),
the Asia Pacific Heart Rhythm Society (APHRS),
and the Society of Thoracic Surgeons (STS).
Endorsed by the governing bodies ofthe American College of Cardiology Foundation,
the American Heart Association,the European Cardiac Arrhythmia Society,
the European Heart Rhythm Association,the Society of Thoracic Surgeons,
the Asia Pacific Heart Rhythm Society,
and the Heart Rhythm Society.Heart Rhythm.
2012 ;9:632-696.
5.- Feuchtner GM,
Dichtl W,
DeFrance T,
Stühlinger M,
Klauser A et al.
Fusion of multislice computed tomography and electroanatomical mapping data for 3D navigation of left and right atrial catheter ablation.
Eur J Radiol.
2008; 68:456-64.
6.- Baman TS,
Jongnarangsin K,
Chugh A,
Suwanagool A,
Guiot A,
et al.
Prevalence and predictors of complications of radiofrequency catheter ablation for atrial fibrillation.
J Cardiovasc Electrophysiol.
2011; 22: 626-631.
7.- Gościniak P,
Kowalik I,
Sielicki P,
Brykczyński M.Predictors of short- and mid-term recurrence of atrial fibrillation after surgical radiofrequency ablation: a six-month transtelephonic electrocardiogram monitoring study.
Cardiol J.
2013;20:499-505.
8.- Patel SN,
French A,
Mathias H,
Lyen S,
Hamilton MC,
et al.
Presence of left atrial diverticula,
accessory appendages,
and normal variant pulmonary venous anatomy diagnosed using MDCT and adverse outcomes following radiofrequency catheter ablation therapy in patients with drug-refractory atrial fibrillation: an exploratory study.
Clin Radiol.
2013;68:762-9.
9.- Viteri-Ramírez G,
García-Lallana A,
Simón-Yarza I,
Broncano J,
Ferreira M,
Pueyo JC,
Villanueva A,
Bastarrika G.
Low radiation and low-contrast dose pulmonary CT angiography: Comparison of 80 kVp/60 ml and 100 kVp/80 ml protocols.
Clin Radiol.
2012;67:833-9.
10.- François CJ,
Tuite D,
Deshpande V,
Jerecic R,
Weale P,
et al.
Pulmonary vein imaging with unenhanced three-dimensional balanced steady-state free precession MR angiography: initial clinical evaluation.
Radiology.
2009 ;250:932-9.
11.- Kaseno K,
Hiroshi H,
Koyama K,
Masaaki Jingu M,
Hiramatsu S et al.
Prevalence and Characterization of Pulmonary Vein Variants in Patients With Atrial Fibrillation Determined Using 3-Dimensional Computed Tomography.
Am J Cardiol 2008;101:1638 –1642.
12.- Kim YH,
Marom EM,
Herndon JE 2nd,
McAdams HP.
Pulmonary vein diameter,
cross-sectional area,
and shape: CT analysis.
Radiology.
2005 ;235:43-9 .
13.- Zalamea RM,
Entrikin DW,
Wannenburg T,
Carr JJ.
Anomalous intracavitary right coronary artery shown by cardiac CT: a potential hazard to be aware of before various interventions.
J Cardiovasc Comput Tomogr.
2009 ;3:57-61.
14.- Baranowski B,
Saliba W.
Our approach to management of patients with pulmonary vein stenosis following AF ablation.
J Cardiovasc Electrophysiol.
2011 ;22:364-7.
15.- Kuwahara T,
Takahashi A,
Takahashi Y,
Kobori A,
Miyazaki S,
et al.
Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases.
J Cardiovasc Electrophysiol.
2013 ;24:847-51.
16.- Ruby RS,
Wells D,
Sankaran S,
Good E,
Jongnarangsin K,
et al.
Prevalence of fever in patients undergoing left atrial ablation of atrial fibrillation guided by barium esophagraphy.
J Cardiovasc Electrophysiol.
2009;20:883-7.
17.- Cappato R,
Calkins H,
Chen SA,
Davies W,
Iesaka Y et al.
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation.J Am Coll Cardiol.
2009 12;53:1798-803.
18.- Martí-Almor J,
Jauregui-Abularach ME,
Benito B,
Vallès E,
Bazan V,
Sánchez-Font A,
Vollmer I,
Altaba C,
Guijo MA,
Hervas M,
Bruguera-Cortada J.
Pulmonary hemorrhage after cryoballoon ablation for pulmonary vein isolation in the treatment of atrial fibrillation.
Chest.
2014 ;145:156-7.
19.- Peyrat E,
Mondoly P,
Chabbert V,
Pontier S,
Escamilla R,
Degano B.
Pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation.
Rev Mal Respir.
2008 ;25:73-7.
20.- Gilkeson RC and Haaga JR.
Anomalous Unilateral Single Pulmonary Vein: Multidetector CT Findings.
Am J Radiol.
2000,
175:1464-1465.
21.- Agarwal PP,
Seely JM,
Matzinger FR.
MDCT of Anomalous Unilateral Single Pulmonary Vein Am J Radiol.
2004;183:1241–1243.
22.- Kuwahara T,
Takahashi A,
Okubo K,
Takagi K,
Yamao K,
et al.
Oesophageal cooling with ice water does not reduce the incidence of oesophageal lesions complicating catheter ablation of atrial fibrillation: randomized controlled study.
Europace.
2014 Jan 26.
23.- Nair KK,
Shurrab M,
Skanes A,
Danon A,
Birnie D,
et al.
The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience.
J Interv Card Electrophysiol.
2013 Dec 7.
24.- Cappato R,
Calkins H,
Chen SA,
Davies W,
Iesaka Y,
et al.
Updated worldwide survey on the methods,
efficacy,
and safety of catheter ablation for human atrial fibrillation.
Circ Arrhythm Electrophysiol 2010;3:32-8.
25.- Cappato R,
Calkins H,
Chen SA,
Davies W,
Iesaka Y et al.
Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report.
J Am Coll Cardiol 2011;58:2696-7.
26.- Peters DC,
Wylie JV,
Hauser TH,
Kissinger KV,
Botnar RM,
Essebag V,
Josephson ME,
Manning WJ.
Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience.
Radiology.
2007 ;243: 690-5.
27.- Pappone C,
Oral H,
Santinelli V,
Vicedomini G,
Lang CC,
Manguso F,
Torracca L,Benussi S,
Alfieri O,
Hong R,
Lau W,
Hirata K,
Shikuma N,
Hall B,
Morady F.
Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.
Circulation.
2004 Jun 8;109(22):2724-6.
Epub 2004 May 24.